Report ID: 10352330 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Europe bioelectric medicine market was valued at $5,859.6 million in 2020 and will grow by 6.4% annually over 2020-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 70 tables and 43 figures, this 141-page report “Europe Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.
Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Implantable Bioelectric Medicine
o Cardiac Pacemaker
o Implantable Cardioverter Defibrillators (ICD)
o Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
o Cochlear Implants
o Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
o Vagus Nerve Stimulators
o Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
o Retinal Implants
o Other Implantable Bioelectric Medicines
• Non-invasive Bioelectric Medicine
o Transcutaneous Electrical Nerve Stimulators
o Transcranial Magnetic Stimulation (TMS)
o Pulsed Electromagnetic Field Therapy
o Other Non-invasive Bioelectric Medicines
Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospitals and Clinics
• Research Institutes
• Individual Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of the regional market by country and split of key national markets by Product Type and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Europe Market by Product Type 40
3.1 Market Overview by Product Type 40
3.2 Implantable Bioelectric Medicine 42
3.2.1 Cardiac Pacemaker 44
3.2.2 Implantable Cardioverter Defibrillators (ICD) 45
3.2.3 Spinal Cord Stimulators 46
3.2.4 Cochlear Implants 47
3.2.5 Deep Brain Stimulators 48
3.2.6 Vagus Nerve Stimulators 49
3.2.7 Sacral Nerve Stimulators 50
3.2.8 Retinal Implants 51
3.2.9 Other Implantable Bioelectric Medicines 52
3.3 Non-invasive Bioelectric Medicine 53
3.3.1 Transcutaneous Electrical Nerve Stimulators 55
3.3.2 Transcranial Magnetic Stimulation (TMS) 56
3.3.3 Pulsed Electromagnetic Field Therapy 57
3.3.4 Other Non-invasive Bioelectric Medicines 58
4 Segmentation of Europe Market by End User 59
4.1 Market Overview by End User 59
4.2 Hospitals and Clinics 61
4.3 Research Institutes 62
4.4 Individual Users 63
5 European Market 2020-2030 by Country 64
5.1 Overview of European Market 64
5.2 Germany 67
5.3 UK 69
5.4 France 71
5.5 Spain 73
5.6 Italy 75
5.7 Russia 77
5.8 Rest of European Market 79
6 Competitive Landscape 81
6.1 Overview of Key Vendors 81
6.2 New Product Launch, Partnership, Investment, and M&A 87
6.3 Company Profiles 88
Abbott Laboratories 88
BIOTRONIK SE & Co. KG 91
Boston Scientific Corporation 95
Cochlear Limited 99
electroCore, Inc. 102
Inspire Medical Systems, Inc. 104
LivaNova PLC 106
Medtronic PLC 108
NeuroMetrix, Inc 112
Nevro Corp. 114
Nuvectra Corporation 116
OMRON CORPORATION 118
Pixium Vision 121
Second Sight Medical Products Inc 124
SetPoint Medical 127
Sonova Holding AG 129
St. Jude Medical, Inc. 131
Stimwave LLC 133
7 Investing in Europe Market: Risk Assessment and Management 135
7.1 Risk Evaluation of Europe Market 135
7.2 Critical Success Factors (CSFs) 138
Related Reports and Products 141
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10352330 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
